An observational study in Hip Fractures and Intraoperative Hypotension, sponsored by Sahlgrenska University Hospital. Completed at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by Sahlgrenska University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Hip Fractures by Sahlgrenska University Hospital — none open to participants now, none under way, none of them phase 3. Hip Fractures · Sahlgrenska University Hospital.
Among the 10 studies in Hip Fractures by Sahlgrenska University Hospital, this one is the only one that started in 2017, is one of 5 observational ones, and was the 5th registered.
843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.
Browse Hip Fractures studies →None of the 10 studies in Hip Fractures by Sahlgrenska University Hospital is open now. The open studies under Hip Fractures, anywhere →
Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 997 is above the median of 149 across 280 observational studies indexed under Hip Fractures.
Median enrollment 84 across the 5 interventional studies, 750 across the 5 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Sahlgrenska University Hospital is the lead sponsor of 263 studies on the registry; 68 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Hip Fractures by Sahlgrenska University Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365- days
The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365-days Confounding factors were; all comorbitity, age, ASA grade as well as type of anesthesia
Single center study of patients operated with an acute hip fracture
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Mortality
Time frame: 365 days
Ran from Jan 2017 to primary completion in Mar 2018, 14 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital →